Article
In vitro studies on the metabolism of trabectedin (YONDELIS) in monkey and man, including human CYP reaction phenotyping.
Biochemical pharmacology - 15 May 2009
Vermeir Marc, Hemeryck Alex, Cuyckens Filip, Francesch Andres, Bockx Marc, Van Houdt Jos, Steemans Kathleen, Mannens Geert, Avilés Pablo, De Coster Roland
Abstract excerpt
Trabectedin (YONDELIS) is a potent anticancer agent which was recently approved in Europe for the treatment of soft tissue sarcoma. The drug is currently also in clinical development for the treatment of ovarian carcinoma. In vitro experiments were conducted to investigate the hepatic metabolism of [(14)C]trabectedin in Cynomolgus monkey and human liver subcellular fractions. The biotransformation of trabectedin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
